Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Short-Term Blinatumomab As a Bridge Therapy for Hematopoietic Stem Cell Transplantation in B-Cell Acute Lymphoblastic Leukemia with Low Leukemia Burden

Hang Zhang, Xinchuan Chen, Tian Dong, Pu Kuang, Zhigang Liu, Yu Wu, Yongqian Jia, Yun Tang, Yang Dai, Ting Niu, Ting Liu, Jie Ji

Blood (2023) 142 (Supplement 1): 234.

https://doi.org/10.1182/blood-2023-189701

Published: 2023

Journal Articles

Herombopag, a Second Generation Thrombopoietin-Receptor Agonist, Stimulates Platelet Engraftment after Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Ailin Zhao, Li Wang, Jinjin Wang, Xin Wang, Zhigang Liu, Pu Kuang, Qiuhui Wu, Jie Ji, Ting Niu

Blood (2023) 142 (Supplement 1): 6957.

https://doi.org/10.1182/blood-2023-188901

Published: 2023

Journal Articles

A Conditioning Regimen of Bendamustine and Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma: A Phase 2, Single-Arm, Prospective Study

Qiang Zeng, Jian Li, Tian Dong, Xinchuan Chen, Pu Kuang, Ting Niu, Jie Ji, Zhigang Liu, Ting Liu

Blood (2023) 142 (Supplement 1): 7066.

https://doi.org/10.1182/blood-2023-174304

Published: 2023

Journal Articles

A Novel Hybrid Transplantation with Autologous Hematopoietic Stem Cells and Matched Unrelated Cord Blood Stem Cells Is Effecttive and Safe for Relapsed or Refractory Lymphoma: A Pilot Study

Blood (2019) 134 (Supplement_1): 5713.

https://doi.org/10.1182/blood-2019-129459

Published: 2019

Journal Articles

Chidamide-Containing Conditioning Allogenic Hematopoietic Stem Cell Transplantation Improves Prognosis of Acute Lymphoblastic Leukemia with Pre-Transplant Response Less Than Complete Remission

Jie Ji, MD, Tian Dong, MD PhD, Pu Kuang, MD PhD, Zhigang Liu, MD, Jiazhuo Liu, MD PhD, Li Zhang, MD, Ting Niu, MD PhD, Ting Liu, MD

Blood (2018) 132 (Supplement 1): 3366.

https://doi.org/10.1182/blood-2018-99-114763

Published: 2018

Journal Articles

Chidamide, a HDAC Inhibitor, Combined with Cladribine, High Dose Gemcitabine and Busulfan with Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory and Poor-Risk Lymphoma

Jie Ji, MD, Ting Liu, MDPhD, Pu Kuang, MD PhD, Zhigang Liu, MD, Tian Dong, MD PhD, Jiazhuo Liu, MD PhD

Blood (2017) 130 (Supplement 1): 3288.

https://doi.org/10.1182/blood.V130.Suppl_1.3288.3288

Published: 2017

Journal Articles

Pilot Study of Safety and Efficacy of Chidamide in Allogenic Peripheral Hematopoietic Stem Cell Transplantation: Better Disease Control and Positively Lower Graft Versus Host Disease

Jie Ji, MD, Ting Liu, MDPhD, Pu Kuang, MD PhD, Zhigang Liu, MD, Tian Dong, MD PhD, Jiazhuo Liu, MD PhD

Blood (2017) 130 (Supplement 1): 4583.

https://doi.org/10.1182/blood.V130.Suppl_1.4583.4583

Published: 2017

Journal Articles

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Pu Kuang, MD, PhD, Yu Wu, MD, PhD, Bing Xiang, MD, Hongbing Ma, MD, Hong Chang, MD, Ting Niu, MD, PhD, Xu Cui, MD, Chuan He, MD, Jianjun Li, MD, Jie Ji, MD, Jie Huang, MD, Tian Dong, MD, PhD, Qing Shenglan, MB, Huaxin Wu, MB, Xiaogong Liang, MSc, Haiying Guo, MB, Chunnong Wu, MB, Ting Liu, MD

Blood (2013) 122 (21): 5019.

https://doi.org/10.1182/blood.V122.21.5019.5019

Published: 2013

Journal Articles

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Ting Liu, MD, Pu Kuang, MD, Tian Dong, MD, Bing Xiang, MD, Jianjun Li, MD, Xinchuan Chen, MD, Chuan He, MD, Hongbing Ma, MD, Jie Ji, MD, Yuping Gong, MD, PhD, Hong Chang, MD, Yu Wu, MD, PhD, Huanling Zhu, MD, Yuchun Wang, MD, PhD

Blood (2011) 118 (21): 4243.

https://doi.org/10.1182/blood.V118.21.4243.4243

Published: 2011

NARROW

Short-Term Blinatumomab As a Bridge Therapy for Hematopoietic Stem Cell Transplantation in B-Cell Acute Lymphoblastic Leukemia with Low Leukemia Burden

Herombopag, a Second Generation Thrombopoietin-Receptor Agonist, Stimulates Platelet Engraftment after Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

A Conditioning Regimen of Bendamustine and Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma: A Phase 2, Single-Arm, Prospective Study

A Novel Hybrid Transplantation with Autologous Hematopoietic Stem Cells and Matched Unrelated Cord Blood Stem Cells Is Effecttive and Safe for Relapsed or Refractory Lymphoma: A Pilot Study

Chidamide-Containing Conditioning Allogenic Hematopoietic Stem Cell Transplantation Improves Prognosis of Acute Lymphoblastic Leukemia with Pre-Transplant Response Less Than Complete Remission

Chidamide, a HDAC Inhibitor, Combined with Cladribine, High Dose Gemcitabine and Busulfan with Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory and Poor-Risk Lymphoma

Pilot Study of Safety and Efficacy of Chidamide in Allogenic Peripheral Hematopoietic Stem Cell Transplantation: Better Disease Control and Positively Lower Graft Versus Host Disease

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only